WashingtonSB 59812025-2026 Regular SessionSenate

Protecting patient access to discounted medications and health care services through Washington's health care safety net by preventing manufacturer limitations on the 340B drug pricing program.

Sponsored By: Annette Cleveland (Democratic)

Signed by Governor

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Bill Overview

Analyzed Economic Effects

3 provisions identified: 1 benefits, 2 costs, 0 mixed.

Stronger drug access protections for safety-net patients

Beginning June 11, 2026, drug makers and their agents cannot block providers from getting discounted drugs through the federal 340B program. This protection covers delivery to providers, contract pharmacies, and provider-approved locations, unless federal law bars receipt. Drug makers also cannot demand claims, drug-use, purchase, or other data as a condition of access unless federal law requires sharing. Covered providers can sue to stop violations; courts can award legal fees and penalties up to $5,000 daily for each violation, with each affected package counted separately. Washington’s Attorney General can also sue for the state or its residents under state consumer protection law. These protections support safety-net drug access but do not guarantee patients a set price or savings.

New drug reporting rules for safety-net providers

Beginning June 11, 2026, Washington federally qualified health centers and specified hospitals must file yearly 340B reports. Reports go to the Washington Health Care Authority by April 1 following the end of each provider’s fiscal year. They must identify the provider and show drug costs, payments, savings, claims, and dispensing or administered-dose counts. Reports also cover pharmacy and program-management payments and expenses, savings uses, pharmacy-claim percentages, and low-income patients served with sliding-scale fees. Commercial insurance, Medicaid, Medicare, and uninsured payer details are required when available. The agency may fine a provider $1,000 daily for missing information, but must first offer a chance to fix it. No fine applies when the provider supplies the required information within 30 calendar days after receiving written notice.

New filing fees for providers and manufacturers

Beginning June 11, 2026, the Washington Health Care Authority may set yearly fees for providers and manufacturers required to report 340B data. These fees must be limited to covering the agency’s data collection and reporting costs; the law sets no dollar amounts. Provider fees must be tiered by gross operating revenue and cannot collectively cover more than 25% of those costs. Manufacturer fees must follow tiers set by the agency. Fee money goes into a dedicated account, and lawmakers must approve spending before the agency uses it solely for 340B data collection and reporting.

Sponsors & Cosponsors

Sponsor

  • Annette Cleveland

    Democratic • Senate

Cosponsors

  • Bob Hasegawa

    Democratic • Senate

  • Emily Alvarado

    Democratic • Senate

  • Jamie Pedersen

    Democratic • Senate

  • Javier Valdez

    Democratic • Senate

  • Jessica Bateman

    Democratic • Senate

  • Manka Dhingra

    Democratic • Senate

  • Marko Liias

    Democratic • Senate

  • Mike Chapman

    Democratic • Senate

  • Noel Frame

    Democratic • Senate

  • Paul Harris

    Republican • Senate

  • Rebecca Saldaña

    Democratic • Senate

  • Vandana Slatter

    Democratic • Senate

Roll Call Votes

All Roll Calls

Yes: 376 • No: 394

Senate vote • 3/9/2026

Final Passage as Amended by the House

Yes: 30 • No: 19

House vote • 3/6/2026

2434 Engell Pg 2 Ln 26

Yes: 40 • No: 56 • Other: 2

House vote • 3/6/2026

2432 Dufault Pg 2 Ln 30

Yes: 38 • No: 58 • Other: 2

House vote • 3/6/2026

2468 Marshall Pg 3 Ln 7

Yes: 43 • No: 53 • Other: 2

House vote • 3/6/2026

2433 Manjarrez Pg 3 Ln 29

Yes: 39 • No: 57 • Other: 2

House vote • 3/6/2026

2457 Marshall Pg 3 Ln 29

Yes: 46 • No: 50 • Other: 2

House vote • 3/6/2026

2435 Abell Pg 3 Ln 7

Yes: 43 • No: 53 • Other: 2

House vote • 3/6/2026

Final Passage as Amended by the House

Yes: 67 • No: 30 • Other: 1

Senate vote • 2/13/2026

3rd Reading & Final Passage

Yes: 30 • No: 18 • Other: 1

Actions Timeline

  1. Effective date 6/11/2026.

    3/25/2026Senate
  2. Chapter 227, 2026 Laws.

    3/25/2026Senate
  3. Governor signed.

    3/25/2026legislature
  4. Delivered to Governor.

    3/12/2026legislature
  5. Speaker signed.

    3/11/2026legislature
  6. President signed.

    3/10/2026legislature
  7. Passed final passage; yeas, 30; nays, 19; absent, 0; excused, 0.

    3/9/2026Senate
  8. Senate concurred in House amendments.

    3/9/2026House
  9. Third reading, passed; yeas, 67; nays, 30; absent, 0; excused, 1.

    3/6/2026Senate
  10. Rules suspended. Placed on Third Reading.

    3/6/2026Senate
  11. Committee amendment(s) adopted with no other amendments.

    3/6/2026Senate
  12. Rules Committee relieved of further consideration. Placed on second reading.

    3/4/2026Senate
  13. Referred to Rules 2 Review.

    3/2/2026Senate
  14. Minority; without recommendation.

    3/2/2026Senate
  15. Minority; do not pass.

    3/2/2026Senate
  16. APP - Majority; do pass with amendment(s) by Health Care & Wellness.

    3/2/2026Senate
  17. APP - Executive action taken by committee.

    3/2/2026Senate
  18. HCW - Executive action taken by committee.

    2/25/2026Senate
  19. Minority; without recommendation.

    2/25/2026Senate
  20. Minority; do not pass.

    2/25/2026Senate
  21. HCW - Majority; do pass with amendment(s).

    2/25/2026Senate
  22. Referred to Appropriations.

    2/25/2026Senate
  23. First reading, referred to Health Care & Wellness.

    2/17/2026Senate
  24. Third reading, passed; yeas, 30; nays, 18; absent, 0; excused, 1.

    2/13/2026Senate
  25. Rules suspended. Placed on Third Reading.

    2/13/2026Senate

Bill Text

Related Bills

Back to State Legislation